Tariffs

News

Tariffs 'could cancel out discounts with biosimilars'

Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit.

News

J&J expecting $400m hit from tariffs in 2025

J&J chief executive Joaquin Duato has told analysts that tax policy, not tariffs, is the key to increasing pharma manufacturing capacity in the US.

News

US starts the clock ticking on pharma tariffs

The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.

News

Novartis radioligand therapy (RLT) manufacturing facility

Novartis plans $23bn manufacturing, R&D spend in US

Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there.

Market Access

Reuters Europe 2025: Trade-offs in European launch sequencin...

At Reuters, industry stakeholders discussed how, especially in light of the current tariff crisis, Europe must operate as a unit when pricing drugs.

News

Pharma warns EU of "exodus to US" without reform

Pharma leaders have told the EU that without reforms the bloc could lose out on major capital investment programmes and R&D spending.

Tariffs 'could cancel out discounts with biosimilars'

J&J expecting $400m hit from tariffs in 2025

US starts the clock ticking on pharma tariffs

Novartis plans $23bn manufacturing, R&D spend in US

Reuters Europe 2025: Trade-offs in European launch sequencin...

Pharma warns EU of "exodus to US" without reform

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Tariffs

Editor's Picks